Alterity Therapeutics ATHE
NASDAQ ATHE
$4.67 +0.22 (+4.94%)
As of: Aug 21, 2026 · 3:59 PM EDT

Alterity Therapeutics (ATHE) Return on Capital Employed Growth (1y) (2010 - 2024)

Alterity Therapeutics (ATHE) Return on Capital Employed Growth (1y) (2010 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 45.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -785.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1,629.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3,193.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -28.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 399.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -310.00
10 Alterity Therapeutics 48.56 Mn 16.26 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 9,431.00
Jun 30, 2023 -18,770.00
Dec 31, 2019 -23,540.00
Jun 30, 2019 12,741.00
Dec 31, 2018 -20.00
Jun 30, 2018 -12,764.00
Dec 31, 2017 4.00
Jun 30, 2010 -2,669.00